- Home
- DRCT vs GDTC Comparison
DRCT vs GDTC Comparison
Compare DRCT & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRCT
- GDTC
- Stock Information
- Founded
- DRCT 2018
- GDTC 2018
- Country
- DRCT United States
- GDTC Singapore
- Employees
- DRCT N/A
- GDTC N/A
- Industry
- DRCT Computer Software: Programming Data Processing
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- DRCT Technology
- GDTC Health Care
- Exchange
- DRCT Nasdaq
- GDTC Nasdaq
- Market Cap
- DRCT 38.7M
- GDTC 33.4M
- IPO Year
- DRCT 2022
- GDTC 2023
- Fundamental
- Price
- DRCT $0.61
- GDTC $2.65
- Analyst Decision
- DRCT Strong Buy
- GDTC Buy
- Analyst Count
- DRCT 3
- GDTC 1
- Target Price
- DRCT $21.00
- GDTC $5.00
- AVG Volume (30 Days)
- DRCT 196.0K
- GDTC 24.7K
- Earning Date
- DRCT 11-12-2024
- GDTC 01-01-0001
- Dividend Yield
- DRCT N/A
- GDTC N/A
- EPS Growth
- DRCT N/A
- GDTC N/A
- EPS
- DRCT N/A
- GDTC N/A
- Revenue
- DRCT $94,216,000.00
- GDTC $330,254.00
- Revenue This Year
- DRCT $17.00
- GDTC $14.71
- Revenue Next Year
- DRCT N/A
- GDTC N/A
- P/E Ratio
- DRCT N/A
- GDTC N/A
- Revenue Growth
- DRCT N/A
- GDTC N/A
- 52 Week Low
- DRCT $0.61
- GDTC $1.20
- 52 Week High
- DRCT $35.88
- GDTC $5.50
- Technical
- Relative Strength Index (RSI)
- DRCT 26.06
- GDTC 51.52
- Support Level
- DRCT $0.61
- GDTC $2.43
- Resistance Level
- DRCT $1.04
- GDTC $3.00
- Average True Range (ATR)
- DRCT 0.14
- GDTC 0.38
- MACD
- DRCT 0.01
- GDTC -0.01
- Stochastic Oscillator
- DRCT 5.73
- GDTC 39.06
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.